BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Swaminathan G, Rossi F, Sierra LJ, Gupta A, Navas-Martín S, Martín-García J. A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages. PLoS Pathog 2012;8:e1002937. [PMID: 23028330 DOI: 10.1371/journal.ppat.1002937] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Majumdar A, Basu A. Involvement of host microRNAs in flavivirus-induced neuropathology: An update. J Biosci 2022;47. [DOI: 10.1007/s12038-022-00288-1] [Reference Citation Analysis]
2 Chinniah R, Adimulam T, Nandlal L, Arumugam T, Ramsuran V. The Effect of miRNA Gene Regulation on HIV Disease. Front Genet 2022;13:862642. [DOI: 10.3389/fgene.2022.862642] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Bazié WW, Boucher J, Traoré IT, Kania D, Somé DY, Alary M, Gilbert C. Vesicular MicroRNA as Potential Biomarkers of Viral Rebound. Cells 2022;11:859. [PMID: 35269481 DOI: 10.3390/cells11050859] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Gibson MS, Noronha-estima C, Gama-carvalho M. Therapeutic Metabolic Reprograming Using microRNAs: From Cancer to HIV Infection. Genes 2022;13:273. [DOI: 10.3390/genes13020273] [Reference Citation Analysis]
5 Qiao J, Peng Q, Qian F, You Q, Feng L, Hu S, Liu W, Huang L, Shu X, Sun B. HIV-1 Vpr protein upregulates microRNA-210-5p expression to induce G2 arrest by targeting TGIF2. PLoS One 2021;16:e0261971. [PMID: 34965271 DOI: 10.1371/journal.pone.0261971] [Reference Citation Analysis]
6 Jafarzadeh A, Naseri A, Shojaie L, Nemati M, Jafarzadeh S, Bannazadeh Baghi H, Hamblin MR, Akhlagh SA, Mirzaei H. MicroRNA-155 and antiviral immune responses. Int Immunopharmacol 2021;101:108188. [PMID: 34626873 DOI: 10.1016/j.intimp.2021.108188] [Reference Citation Analysis]
7 Rojas M, Luz-Crawford P, Soto-Rifo R, Reyes-Cerpa S, Toro-Ascuy D. The Landscape of IFN/ISG Signaling in HIV-1-Infected Macrophages and Its Possible Role in the HIV-1 Latency. Cells 2021;10:2378. [PMID: 34572027 DOI: 10.3390/cells10092378] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Salazar C, Galaz M, Ojeda N, Marshall SH. Expression of ssa-miR-155 during ISAV infection in vitro: Putative role as a modulator of the immune response in Salmo salar. Dev Comp Immunol 2021;122:104109. [PMID: 33930457 DOI: 10.1016/j.dci.2021.104109] [Reference Citation Analysis]
9 Bazié WW, Boucher J, Vitry J, Goyer B, Routy JP, Tremblay C, Trottier S, Jenabian MA, Provost P, Alary M, Gilbert C. Plasma Extracellular Vesicle Subtypes May be Useful as Potential Biomarkers of Immune Activation in People With HIV. Pathog Immun 2021;6:1-28. [PMID: 33987483 DOI: 10.20411/pai.v6i1.384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zheng Y, Yang Z, Jin C, Chen C, Wu N. hsa-miR-191-5p inhibits replication of human immunodeficiency virus type 1 by downregulating the expression of NUP50. Arch Virol 2021;166:755-66. [PMID: 33420627 DOI: 10.1007/s00705-020-04899-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mielcarska MB, Gregorczyk-Zboroch KP, Szulc-Da̧browska L, Bossowska-Nowicka M, Wyżewski Z, Cymerys J, Chodkowski M, Kiełbik P, Godlewski MM, Gieryńska M, Toka FN. Participation of Endosomes in Toll-Like Receptor 3 Transportation Pathway in Murine Astrocytes. Front Cell Neurosci 2020;14:544612. [PMID: 33281554 DOI: 10.3389/fncel.2020.544612] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Huang Y, Huang X, Zheng H, Lin C, Lin Z. Homogeneous electrochemical biosensor for microRNA based on enzyme-driven cascaded signal amplification strategy. Anal Bioanal Chem 2021;413:4681-8. [PMID: 33185746 DOI: 10.1007/s00216-020-03027-3] [Reference Citation Analysis]
13 Yousefpouran S, Mostafaei S, Manesh PV, Iranifar E, Bokharaei-salim F, Nahand JS, Mirzaei H, Taran M, Babaei F, Sayad B, Moghoofei M. The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker. Microbial Pathogenesis 2020;147:104355. [DOI: 10.1016/j.micpath.2020.104355] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
14 Lodge R, Bellini N, Laporte M, Salahuddin S, Routy JP, Ancuta P, Costiniuk CT, Jenabian MA, Cohen ÉA. Interleukin-1β Triggers p53-Mediated Downmodulation of CCR5 and HIV-1 Entry in Macrophages through MicroRNAs 103 and 107. mBio 2020;11:e02314-20. [PMID: 32994328 DOI: 10.1128/mBio.02314-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Covino DA, Kaczor-Urbanowicz KE, Lu J, Chiantore MV, Fiorucci G, Vescio MF, Catapano L, Purificato C, Galluzzo CM, Amici R, Andreotti M, Gauzzi MC, Pellegrini M, Fantuzzi L. Transcriptome Profiling of Human Monocyte-Derived Macrophages Upon CCL2 Neutralization Reveals an Association Between Activation of Innate Immune Pathways and Restriction of HIV-1 Gene Expression. Front Immunol 2020;11:2129. [PMID: 33072075 DOI: 10.3389/fimmu.2020.02129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Nguyen H, Gazy N, Venketaraman V. A Role of Intracellular Toll-Like Receptors (3, 7, and 9) in Response to Mycobacterium tuberculosis and Co-Infection with HIV. Int J Mol Sci 2020;21:E6148. [PMID: 32858917 DOI: 10.3390/ijms21176148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chen L, Ishigami T, Doi H, Arakawa K, Tamura K. Gut microbiota and atherosclerosis: role of B cell for atherosclerosis focusing on the gut-immune-B2 cell axis. J Mol Med (Berl) 2020;98:1235-44. [PMID: 32737524 DOI: 10.1007/s00109-020-01936-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Ayala-Suárez R, Díez-Fuertes F, Calonge E, De La Torre Tarazona HE, Gracia-Ruíz de Alda M, Capa L, Alcamí J. Insight in miRNome of Long-Term Non-Progressors and Elite Controllers Exposes Potential RNAi Role in Restraining HIV-1 Infection. J Clin Med 2020;9:E2452. [PMID: 32751854 DOI: 10.3390/jcm9082452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 da Silva TP, Bittencourt TL, de Oliveira AL, Prata RBDS, Menezes V, Ferreira H, Nery JADC, de Oliveira EB, Sperandio da Silva GM, Sarno EN, Pinheiro RO. Macrophage Polarization in Leprosy-HIV Co-infected Patients. Front Immunol 2020;11:1493. [PMID: 32849508 DOI: 10.3389/fimmu.2020.01493] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Wang MR, Wu DD, Luo F, Zhong CJ, Wang X, Zhu N, Wu YJ, Hu HT, Feng Y, Wang X, Xiong HR, Hou W. Methadone Inhibits Viral Restriction Factors and Facilitates HIV Infection in Macrophages. Front Immunol 2020;11:1253. [PMID: 32719674 DOI: 10.3389/fimmu.2020.01253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
21 Goh JY, O'Sullivan SE, Shortall SE, Zordan N, Piccinini AM, Potter HG, Fone KCF, King MV. Gestational poly(I:C) attenuates, not exacerbates, the behavioral, cytokine and mTOR changes caused by isolation rearing in a rat 'dual-hit' model for neurodevelopmental disorders. Brain Behav Immun 2020;89:100-17. [PMID: 32485291 DOI: 10.1016/j.bbi.2020.05.076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
22 Liu H, Zhou RH, Liu Y, Guo L, Wang X, Hu WH, Ho WZ. HIV infection suppresses TLR3 activation-mediated antiviral immunity in microglia and macrophages. Immunology 2020;160:269-79. [PMID: 32053234 DOI: 10.1111/imm.13181] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
23 Su YC, Huang YF, Wu YW, Chen HF, Wu YH, Hsu CC, Hsu YC, Lee JC. MicroRNA-155 inhibits dengue virus replication by inducing heme oxygenase-1-mediated antiviral interferon responses. FASEB J 2020;34:7283-94. [PMID: 32277848 DOI: 10.1096/fj.201902878R] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
24 Dong B, Borjabad A, Kelschenbach J, Chao W, Volsky DJ, Potash MJ. Prevention and treatment of HIV infection and cognitive disease in mice by innate immune responses. Brain Behav Immun Health 2020;3:100054. [PMID: 32699842 DOI: 10.1016/j.bbih.2020.100054] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Natekar JP, Rothan HA, Arora K, Strate PG, Kumar M. Cellular microRNA-155 Regulates Virus-Induced Inflammatory Response and Protects against Lethal West Nile Virus Infection. Viruses 2019;12:E9. [PMID: 31861621 DOI: 10.3390/v12010009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
26 Sadri Nahand J, Bokharaei-Salim F, Karimzadeh M, Moghoofei M, Karampoor S, Mirzaei HR, Tabibzadeh A, Jafari A, Ghaderi A, Asemi Z, Mirzaei H, Hamblin MR. MicroRNAs and exosomes: key players in HIV pathogenesis. HIV Med 2020;21:246-78. [PMID: 31756034 DOI: 10.1111/hiv.12822] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
27 Bayraktar R, Bertilaccio MTS, Calin GA. The Interaction Between Two Worlds: MicroRNAs and Toll-Like Receptors. Front Immunol 2019;10:1053. [PMID: 31139186 DOI: 10.3389/fimmu.2019.01053] [Cited by in Crossref: 46] [Cited by in F6Publishing: 58] [Article Influence: 15.3] [Reference Citation Analysis]
28 Zhou X, Tao H, Cai Y, Cui L, Zhao B, Li K. Stage-dependent involvement of ADAM10 and its significance in epileptic seizures. J Cell Mol Med 2019;23:4494-504. [PMID: 31087543 DOI: 10.1111/jcmm.14307] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
29 Puhl AC, Garzino Demo A, Makarov VA, Ekins S. New targets for HIV drug discovery. Drug Discov Today 2019;24:1139-47. [PMID: 30885676 DOI: 10.1016/j.drudis.2019.03.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
30 Azouz F, Arora K, Krause K, Nerurkar VR, Kumar M. Integrated MicroRNA and mRNA Profiling in Zika Virus-Infected Neurons. Viruses 2019;11:E162. [PMID: 30781519 DOI: 10.3390/v11020162] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
31 Arboleda JF, Fernandez GJ, Urcuqui-Inchima S. Vitamin D-mediated attenuation of miR-155 in human macrophages infected with dengue virus: Implications for the cytokine response. Infect Genet Evol 2019;69:12-21. [PMID: 30639520 DOI: 10.1016/j.meegid.2018.12.033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
32 Giri BR, Mahato RI, Cheng G. Roles of microRNAs in T cell immunity: Implications for strategy development against infectious diseases. Med Res Rev 2019;39:706-32. [PMID: 30272819 DOI: 10.1002/med.21539] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
33 Moghoofei M, Bokharaei-salim F, Esghaei M, Keyvani H, Honardoost M, Mostafaei S, Ghasemi A, Tavakoli A, Javanmard D, Babaei F, Garshasbi S, Monavari SH. microRNAs 29, 150, 155, 223 level and their relation to viral and immunological markers in HIV-1 infected naive patients. Future Virology 2018;13:637-45. [DOI: 10.2217/fvl-2018-0055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
34 Rodríguez-Valentín M, López S, Rivera M, Ríos-Olivares E, Cubano L, Boukli NM. Naturally Derived Anti-HIV Polysaccharide Peptide (PSP) Triggers a Toll-Like Receptor 4-Dependent Antiviral Immune Response. J Immunol Res 2018;2018:8741698. [PMID: 30116757 DOI: 10.1155/2018/8741698] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
35 Lodge R, Ferreira Barbosa JA, Lombard-Vadnais F, Gilmore JC, Deshiere A, Gosselin A, Wiche Salinas TR, Bego MG, Power C, Routy JP, Ancuta P, Tremblay MJ, Cohen ÉA. Host MicroRNAs-221 and -222 Inhibit HIV-1 Entry in Macrophages by Targeting the CD4 Viral Receptor. Cell Rep 2017;21:141-53. [PMID: 28978468 DOI: 10.1016/j.celrep.2017.09.030] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
36 Wang B, Fu M, Liu Y, Wang Y, Li X, Cao H, Zheng SJ. gga-miR-155 Enhances Type I Interferon Expression and Suppresses Infectious Burse Disease Virus Replication via Targeting SOCS1 and TANK. Front Cell Infect Microbiol 2018;8:55. [PMID: 29564226 DOI: 10.3389/fcimb.2018.00055] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
37 Balasubramaniam M, Pandhare J, Dash C. Are microRNAs Important Players in HIV-1 Infection? Viruses. 2018;10:110. [PMID: 29510515 DOI: 10.3390/v10030110] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
38 Zhang X, Ma X, Jing S, Zhang H, Zhang Y. Non-coding RNAs and retroviruses. Retrovirology 2018;15:20. [PMID: 29426337 DOI: 10.1186/s12977-018-0403-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
39 Waugh CA, Arukwe A, Jaspers VLB. Deregulation of microRNA-155 and its transcription factor NF-kB by polychlorinated biphenyls during viral infections. APMIS 2018;126:234-40. [PMID: 29380441 DOI: 10.1111/apm.12811] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
40 Lodge R, Gilmore JC, Ferreira Barbosa JA, Lombard-Vadnais F, Cohen ÉA. Regulation of CD4 Receptor and HIV-1 Entry by MicroRNAs-221 and -222 during Differentiation of THP-1 Cells. Viruses 2017;10:E13. [PMID: 29301198 DOI: 10.3390/v10010013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
41 Henrick BM, Yao XD, Nasser L, Roozrogousheh A, Rosenthal KL. Breastfeeding Behaviors and the Innate Immune System of Human Milk: Working Together to Protect Infants against Inflammation, HIV-1, and Other Infections. Front Immunol 2017;8:1631. [PMID: 29238342 DOI: 10.3389/fimmu.2017.01631] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
42 Frattari G, Aagaard L, Denton PW. The role of miR-29a in HIV-1 replication and latency. Journal of Virus Eradication 2017;3:185-91. [DOI: 10.1016/s2055-6640(20)30322-8] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
43 Huang J, Zhu L, Qiu C, Xu X, Zhang L, Ding X, Liao Q, Xu J, Zhang X. MicroRNA miR-126-5p Enhances the Inflammatory Responses of Monocytes to Lipopolysaccharide Stimulation by Suppressing Cylindromatosis in Chronic HIV-1 Infection. J Virol 2017;91:e02048-16. [PMID: 28250134 DOI: 10.1128/JVI.02048-16] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
44 Jiao T, Yao Y, Zhang B, Hao DC, Sun QF, Li JB, Yuan C, Jing B, Wang YP, Wang HY. Role of MicroRNA-103a Targeting ADAM10 in Abdominal Aortic Aneurysm. Biomed Res Int 2017;2017:9645874. [PMID: 28357407 DOI: 10.1155/2017/9645874] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
45 Dickey LL, Hanley TM, Huffaker TB, Ramstead AG, O'Connell RM, Lane TE. MicroRNA 155 and viral-induced neuroinflammation. J Neuroimmunol 2017;308:17-24. [PMID: 28139244 DOI: 10.1016/j.jneuroim.2017.01.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
46 Piedade D, Azevedo-Pereira JM. MicroRNAs, HIV and HCV: a complex relation towards pathology. Rev Med Virol. 2016;26:197-215. [PMID: 27059433 DOI: 10.1002/rmv.1881] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
47 Yu SL, Deng H, Li XH, Huang YX, Xie DY, Gao ZL. Expression of MicroRNA-155 is Downregulated in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B Patients. Hepat Mon 2016;16:e34483. [PMID: 27110261 DOI: 10.5812/hepatmon.34483] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
48 Bhargavan B, Woollard SM, Kanmogne GD. Toll-like receptor-3 mediates HIV-1 transactivation via NFκB and JNK pathways and histone acetylation, but prolonged activation suppresses Tat and HIV-1 replication. Cell Signal 2016;28:7-22. [PMID: 26569339 DOI: 10.1016/j.cellsig.2015.11.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
49 Pilakka-Kanthikeel S, Nair MP. Interaction of drugs of abuse and microRNA with HIV: a brief review. Front Microbiol 2015;6:967. [PMID: 26483757 DOI: 10.3389/fmicb.2015.00967] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
50 Rice AP. Roles of microRNAs and long-noncoding RNAs in human immunodeficiency virus replication. Wiley Interdiscip Rev RNA 2015;6:661-70. [PMID: 26394053 DOI: 10.1002/wrna.1308] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
51 Witjes JJ, van Raalte DH, Nieuwdorp M. About the gut microbiome as a pharmacological target in atherosclerosis. European Journal of Pharmacology 2015;763:75-8. [DOI: 10.1016/j.ejphar.2015.06.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
52 Donninelli G, Gessani S, Del Cornò M. Interplay between HIV-1 and Toll-like receptors in human myeloid cells: friend or foe in HIV-1 pathogenesis? J Leukoc Biol 2016;99:97-105. [PMID: 26307548 DOI: 10.1189/jlb.4VMR0415-160R] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
53 Wang L, Li G, Yao ZQ, Moorman JP, Ning S. MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV. Rev Med Virol 2015;25:320-41. [PMID: 26258805 DOI: 10.1002/rmv.1850] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
54 Ochs RL, Mahler M, Basu A, Rios-Colon L, Sanchez TW, Andrade LE, Fritzler MJ, Casiano CA. The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding. Clin Exp Med 2016;16:273-93. [PMID: 26088181 DOI: 10.1007/s10238-015-0367-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 6.1] [Reference Citation Analysis]
55 Zeng FR, Tang LJ, He Y, Garcia RC. An update on the role of miRNA-155 in pathogenic microbial infections. Microbes Infect. 2015;17:613-621. [PMID: 26072128 DOI: 10.1016/j.micinf.2015.05.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
56 Pulliam L, Gupta A. Modulation of cellular function through immune-activated exosomes. DNA Cell Biol 2015;34:459-63. [PMID: 25945690 DOI: 10.1089/dna.2015.2884] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
57 Ruelas DS, Chan JK, Oh E, Heidersbach AJ, Hebbeler AM, Chavez L, Verdin E, Rape M, Greene WC. MicroRNA-155 Reinforces HIV Latency. J Biol Chem 2015;290:13736-48. [PMID: 25873391 DOI: 10.1074/jbc.M115.641837] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
58 Barichievy S, Naidoo J, Mhlanga MM. Non-coding RNAs and HIV: viral manipulation of host dark matter to shape the cellular environment. Front Genet 2015;6:108. [PMID: 25859257 DOI: 10.3389/fgene.2015.00108] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
59 Sarkar N, Panigrahi R, Pal A, Biswas A, Singh SP, Kar SK, Bandopadhyay M, Das D, Saha D, Kanda T, Sugiyama M, Chakrabarti S, Banerjee A, Chakravarty R. Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C/EBP- β in hepatocytes. J Viral Hepat 2015;22:817-27. [DOI: 10.1111/jvh.12390] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
60 Farberov L, Herzig E, Modai S, Isakov O, Hizi A, Shomron N. MicroRNA-mediated regulation of p21 and TASK1 cellular restriction factors enhances HIV-1 infection. J Cell Sci 2015;128:1607-16. [PMID: 25717002 DOI: 10.1242/jcs.167817] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
61 Suzuki K, Ahlenstiel C, Marks K, Kelleher AD. Promoter Targeting RNAs: Unexpected Contributors to the Control of HIV-1 Transcription. Mol Ther Nucleic Acids 2015;4:e222. [PMID: 25625613 DOI: 10.1038/mtna.2014.67] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
62 Gibbert K, Francois S, Sigmund AM, Harper MS, Barrett BS, Kirchning CJ, Lu M, Santiago ML, Dittmer U. Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3. Retrovirology 2014;11:126. [PMID: 25539593 DOI: 10.1186/s12977-014-0126-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
63 Zhou ZX, Zhang BC, Sun L. Poly(I:C) induces antiviral immune responses in Japanese flounder (Paralichthys olivaceus) that require TLR3 and MDA5 and is negatively regulated by Myd88. PLoS One 2014;9:e112918. [PMID: 25393122 DOI: 10.1371/journal.pone.0112918] [Cited by in Crossref: 54] [Cited by in F6Publishing: 227] [Article Influence: 6.8] [Reference Citation Analysis]
64 Swaminathan G, Pascual D, Rival G, Perales-Linares R, Martin-Garcia J, Navas-Martin S. Hepatitis C virus core protein enhances HIV-1 replication in human macrophages through TLR2, JNK, and MEK1/2-dependent upregulation of TNF-α and IL-6. FEBS Lett 2014;588:3501-10. [PMID: 25131930 DOI: 10.1016/j.febslet.2014.08.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
65 Schlaepfer E, Rochat MA, Duo L, Speck RF. Triggering TLR2, -3, -4, -5, and -8 reinforces the restrictive nature of M1- and M2-polarized macrophages to HIV. J Virol 2014;88:9769-81. [PMID: 24942590 DOI: 10.1128/JVI.01053-14] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
66 Pareek S, Roy S, Kumari B, Jain P, Banerjee A, Vrati S. MiR-155 induction in microglial cells suppresses Japanese encephalitis virus replication and negatively modulates innate immune responses. J Neuroinflammation 2014;11:97. [PMID: 24885259 DOI: 10.1186/1742-2094-11-97] [Cited by in Crossref: 70] [Cited by in F6Publishing: 79] [Article Influence: 8.8] [Reference Citation Analysis]
67 Zhou A, Li S, Wu J, Khan FA, Zhang S. Interplay between microRNAs and host pathogen recognition receptors (PRRs) signaling pathways in response to viral infection. Virus Research 2014;184:1-6. [DOI: 10.1016/j.virusres.2014.01.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
68 Endsley MA, Somasunderam AD, Li G, Oezguen N, Thiviyanathan V, Murray JL, Rubin DH, Hodge TW, O'Brien WA, Lewis B, Ferguson MR. Nuclear trafficking of the HIV-1 pre-integration complex depends on the ADAM10 intracellular domain. Virology 2014;454-455:60-6. [PMID: 24725932 DOI: 10.1016/j.virol.2014.02.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
69 Wang Z, Filgueiras LR, Wang S, Serezani AP, Peters-Golden M, Jancar S, Serezani CH. Leukotriene B4 enhances the generation of proinflammatory microRNAs to promote MyD88-dependent macrophage activation. J Immunol. 2014;192:2349-2356. [PMID: 24477912 DOI: 10.4049/jimmunol.1302982] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
70 Swaminathan S, Murray DD, Kelleher AD. miRNAs and HIV: unforeseen determinants of host-pathogen interaction. Immunol Rev 2013;254:265-80. [PMID: 23772625 DOI: 10.1111/imr.12077] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
71 Napuri J, Pilakka-Kanthikeel S, Raymond A, Agudelo M, Yndart-Arias A, Saxena SK, Nair M. Cocaine enhances HIV-1 infectivity in monocyte derived dendritic cells by suppressing microRNA-155. PLoS One 2013;8:e83682. [PMID: 24391808 DOI: 10.1371/journal.pone.0083682] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
72 Swaminathan G, Navas-Martín S, Martín-García J. MicroRNAs and HIV-1 infection: antiviral activities and beyond. J Mol Biol 2014;426:1178-97. [PMID: 24370931 DOI: 10.1016/j.jmb.2013.12.017] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 8.1] [Reference Citation Analysis]
73 Perales-Linares R, Navas-Martin S. Toll-like receptor 3 in viral pathogenesis: friend or foe? Immunology 2013;140:153-67. [PMID: 23909285 DOI: 10.1111/imm.12143] [Cited by in Crossref: 69] [Cited by in F6Publishing: 67] [Article Influence: 7.7] [Reference Citation Analysis]
74 Swaminathan G, Martin-Garcia J, Navas-Martin S. RNA viruses and microRNAs: challenging discoveries for the 21st century. Physiol Genomics 2013;45:1035-48. [PMID: 24046280 DOI: 10.1152/physiolgenomics.00112.2013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
75 Gupta P, Saksena NK. miRNAs: small molecules with a big impact on HIV infection and pathogenesis. Future Virology 2013;8:769-81. [DOI: 10.2217/fvl.13.59] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
76 Aalaei-andabili SH, Rezaei N. Toll like receptor (TLR)-induced differential expression of microRNAs (MiRs) promotes proper immune response against infections: a systematic review. J Infect 2013;67:251-64. [PMID: 23850616 DOI: 10.1016/j.jinf.2013.07.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
77 Alfano M, Graziano F, Genovese L, Poli G. Macrophage Polarization at the Crossroad Between HIV-1 Infection and Cancer Development. ATVB 2013;33:1145-52. [DOI: 10.1161/atvbaha.112.300171] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
78 Seya T, Azuma M, Matsumoto M. Targeting TLR3 with no RIG-I/MDA5 activation is effective in immunotherapy for cancer. Expert Opinion on Therapeutic Targets 2013;17:533-44. [DOI: 10.1517/14728222.2013.765407] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
79 De Iaco A, Santoni F, Vannier A, Guipponi M, Antonarakis S, Luban J. TNPO3 protects HIV-1 replication from CPSF6-mediated capsid stabilization in the host cell cytoplasm. Retrovirology 2013;10:20. [PMID: 23414560 DOI: 10.1186/1742-4690-10-20] [Cited by in Crossref: 108] [Cited by in F6Publishing: 102] [Article Influence: 12.0] [Reference Citation Analysis]
80 Gupta A, Swaminathan G, Martin-Garcia J, Navas-Martin S. MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy. Viruses 2012;4:2485-513. [PMID: 23202492 DOI: 10.3390/v4112485] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]